Dashboard
Manage Tickers

IMNMImmunome Inc.

Nasdaq immunome.com


$ 14.94 $ 0.23 (1.56 %)    

Friday, 31-May-2024 15:59:42 EDT
CLICK TO SEE RELEVANT LITIGATION UPDATES
Y-mAbs Therapeutics, Inc. | YMAB | Take Action!
QQQ $ 454.82 $ -0.84 (-0.19 %)
DIA $ 398.57 $ 6.05 (1.59 %)
SPY $ 530.36 $ 4.76 (0.91 %)
TLT $ 91.26 $ 0.61 (0.68 %)
GLD $ 225.37 $ -1.27 (-0.59 %)
$ 14.94
$ 15.15
$ 14.90 x 300
$ 0.00 x 0
$ 14.64 - $ 15.73
$ 4.50 - $ 30.96
1,588,124
na
770.07M
$ 1.66
nm
TBD
na
na ($ 0.00)
na
TBD na
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
1 05-14-2024 03-31-2024 10-Q
2 03-28-2024 12-31-2023 10-K
3 11-09-2023 09-30-2023 10-Q
4 08-09-2023 06-30-2023 10-Q
5 05-05-2023 03-31-2023 10-Q
6 03-16-2023 12-31-2022 10-K
7 11-14-2022 09-30-2022 10-Q
8 08-05-2022 06-30-2022 10-Q
9 05-12-2022 03-31-2022 10-Q
10 03-28-2022 12-31-2021 10-K
11 11-15-2021 09-30-2021 10-Q
12 08-16-2021 06-30-2021 10-Q
13 05-12-2021 03-31-2021 10-Q
14 03-25-2021 12-31-2020 10-K
15 11-16-2020 09-30-2020 10-Q
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

evaluating-immunome-insights-from-4-financial-analysts
Evaluating Immunome: Insights From 4 Finan...
05/31/2024 13:00:25

piper-sandler-initiates-coverage-on-immunome-with-overweight-rating-announces-price-target-of-27
Piper Sandler Initiates Coverage On Immuno...
05/31/2024 09:58:23

Piper Sandler analyst Biren Amin initiates coverage on Immunome (NASDAQ:IMNM) with a Overweight rating and announces Price T...

over-13m-bet-on-profrac-holding-check-out-these-4-stocks-insiders-are-buying
Over $13M Bet On ProFrac Holding? Check Ou...
05/22/2024 13:09:28

12-health-care-stocks-moving-in-tuesdays-after-market-session
12 Health Care Stocks Moving In Tuesday's ...
05/21/2024 20:31:00

immunome-form-4-filing-shows-president-and-ceo-clay-b-siegall-bought-100000-shares-of-stock-at-a-price-of-1388share
Immunome Form 4 Filing Shows President And...
05/21/2024 20:27:08

-  SEC Filing

immunome-promotes-max-rosett-to-cfo-effective-may-9
Immunome Promotes Max Rosett To CFO, Effec...
05/17/2024 12:05:01

Rosett most recently held the role of Executive Vice President, Operations, in addition to serving as Immunome's Interim Ch...

immunome-q1-eps-251-misses-069-estimate-sales-103m-miss-250m-estimate
Immunome Q1 EPS $(2.51) Misses $(0.69) Est...
05/14/2024 12:18:20

Immunome (NASDAQ:IMNM) reported quarterly losses of $(2.51) per share which missed the analyst consensus estimate of $(0.69) by...

correction-immunome-did-not-report-q1-earnings-on-may-13-2024
CORRECTION: Immunome Did Not Report Q1 Ear...
05/13/2024 12:25:36

jp-morgan-initiates-coverage-on-immunome-with-overweight-rating-announces-price-target-of-24
JP Morgan Initiates Coverage On Immunome w...
04/30/2024 12:45:00

JP Morgan analyst Brian Cheng initiates coverage on Immunome (NASDAQ:IMNM) with a Overweight rating and announces Price Targ...

guggenheim-initiates-coverage-on-immunome-with-buy-rating-announces-price-target-of-35
Guggenheim Initiates Coverage On Immunome ...
04/15/2024 10:34:05

Guggenheim analyst Michael Schmidt initiates coverage on Immunome (NASDAQ:IMNM) with a Buy rating and announces Price Target...

immunome-files-for-shelf-of-up-to-22m-shares-of-common-stock-by-selling-stockholder
Immunome Files For Shelf Of Up To 2.2M Sha...
04/03/2024 20:51:13

- SEC Filing

immunome-inc-filed-prospectus-relates-to-proposed-resale-from-time-to-time-by-selling-stockholder-of-23m-shares-or-shares-of-common-stock
Immunome Inc Filed Prospectus Relates To P...
04/03/2024 20:49:31

- SEC Filing

wedbush-maintains-outperform-on-immunome-raises-price-target-to-33
Wedbush Maintains Outperform on Immunome, ...
04/01/2024 11:58:37

Wedbush analyst David Nierengarten maintains Immunome (NASDAQ:IMNM) with a Outperform and raises the price target from $27 t...

immunome-q4-adj-eps-015-beats-028-estimate-sales-383m-beat-207m-estimate
Immunome Q4 Adj EPS $(0.15) Beats $(0.28) ...
03/29/2024 03:37:37

Immunome (NASDAQ:IMNM) reported quarterly losses of $(0.15) per share which beat the analyst consensus estimate of $(0.28) by 4...

stocks-pause-as-traders-reassess-interest-rate-path-gold-makes-new-highs-bitcoin-rebounds-whats-driving-markets-thursday
Stocks Pause As Traders Reassess Interest ...
03/28/2024 17:49:57

In the final session of the short trading week leading up to Easter festivities, U.S. equity indices held steady, reflecting so...

worthington-steel-posts-upbeat-results-joins-summit-midstream-partners-fedex-and-other-big-stocks-moving-higher-on-friday
Worthington Steel Posts Upbeat Results, Jo...
03/22/2024 14:08:47

U.S. stocks were mixed, with the Dow Jones index falling around 50 points on Friday.

immunome-selects-arrayjets-arrayplex-platform-for-use-in-its-discovery-of-targeted-cancer-therapies
Immunome Selects Arrayjet's ArrayPlex Plat...
03/18/2024 09:51:29

Arrayjet, a leading provider of inkjet liquid-handling solutions, today announced that its ArrayPlex™ discovery platform has be...

biotech-stocks-surge-to-start-2024-charts-look-great-but-will-the-trend-continue
Biotech Stocks Surge To Start 2024: 'Chart...
02/28/2024 17:51:20

The biotech sector has been surging in recent months, reawakening from a period of underperformance that followed the highs of ...

imunon-inc-announces-imnn-101-preclinical-data-in-sars-cov-2-published-in-peer-reviewed-journal-vaccine
IMUNON, Inc. Announces IMNN-101 Preclinica...
02/22/2024 13:25:47

Data Show Strong Immunogenicity and Protection with IMUNON's PlaCCine DNA-Based Vaccine ModalityLAWRENCEVILLE, N.J., Feb. 2...

Core News & Articles
Immunome Recognizes Ayala Pharmaceuticals'...
02/20/2024 13:17:43

– Immunome entered into a definitive asset purchase agreement with Ayala to acquire AL102 earlier this month –

CORE & Plaid

CORE & Plaid

CORE Finalist

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION